Article: Epidemiology and clinical features of Shewanella infection over an eight-year period

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleEpidemiology and clinical features of Shewanella infection over an eight-year period
AuthorsTo, KKW
Wong, SSY
Cheng, VCC
Tang, BSF
Li, IWS
Chan, JFW
Seto, WK
Tse, H
Yuen, KY
Issue Date2010
PublisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/00365548.asp
CitationScandinavian Journal Of Infectious Diseases, 2010, v. 42 n. 10, p. 757-762 [How to Cite?]
DOI: http://dx.doi.org/10.3109/00365548.2010.490562
AbstractShewanella is a rare human pathogen that can lead to fatal infections. However, clinical information about this bacterium remains scarce. In this study, we retrospectively reviewed all patients with laboratory isolates of Shewanella over an 8-y period to assess risk factors, clinical manifestations and outcome. Twenty-nine patients were identified. Shewanella was most commonly isolated from intra-abdominal specimens (48.2%), followed by skin and soft tissue specimens (27.6%), blood (13.8%) and sputum (10.3%). Malignancy, hepatobiliary disease and diabetes mellitus were common underlying diseases. The overall 30-day mortality rate was 20.6%. Shewanella was considered a definite causative pathogen in 7 patients, and a recurrent infection occurred in 2 patients. Colonization of the biliary tract was common. Among co-isolated pathogens, the enteric flora was most represented. All isolates were susceptible to ceftazidime and aminoglycosides, but 1 isolate was resistant to imipenem. In conclusion, Shewanella may become a colonizing bacterium, subsequently causing invasive diseases in patients with an underlying disease. © 2010 Informa Healthcare.
ISSN0036-5548
2011 Impact Factor: 1.722
2011 SCImago Journal Rankings: 0.145
DOIhttp://dx.doi.org/10.3109/00365548.2010.490562
ISI Accession Number IDWOS:000282987100006
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorTo, KKW
dc.contributor.authorWong, SSY
dc.contributor.authorCheng, VCC
dc.contributor.authorTang, BSF
dc.contributor.authorLi, IWS
dc.contributor.authorChan, JFW
dc.contributor.authorSeto, WK
dc.contributor.authorTse, H
dc.contributor.authorYuen, KY
dc.date.accessioned2010-12-23T10:31:28Z
dc.date.available2010-12-23T10:31:28Z
dc.date.issued2010
dc.description.abstractShewanella is a rare human pathogen that can lead to fatal infections. However, clinical information about this bacterium remains scarce. In this study, we retrospectively reviewed all patients with laboratory isolates of Shewanella over an 8-y period to assess risk factors, clinical manifestations and outcome. Twenty-nine patients were identified. Shewanella was most commonly isolated from intra-abdominal specimens (48.2%), followed by skin and soft tissue specimens (27.6%), blood (13.8%) and sputum (10.3%). Malignancy, hepatobiliary disease and diabetes mellitus were common underlying diseases. The overall 30-day mortality rate was 20.6%. Shewanella was considered a definite causative pathogen in 7 patients, and a recurrent infection occurred in 2 patients. Colonization of the biliary tract was common. Among co-isolated pathogens, the enteric flora was most represented. All isolates were susceptible to ceftazidime and aminoglycosides, but 1 isolate was resistant to imipenem. In conclusion, Shewanella may become a colonizing bacterium, subsequently causing invasive diseases in patients with an underlying disease. © 2010 Informa Healthcare.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationScandinavian Journal Of Infectious Diseases, 2010, v. 42 n. 10, p. 757-762 [How to Cite?]
DOI: http://dx.doi.org/10.3109/00365548.2010.490562
dc.identifier.doihttp://dx.doi.org/10.3109/00365548.2010.490562
dc.identifier.epage762
dc.identifier.hkuros178247
dc.identifier.hkuros213670
dc.identifier.isiWOS:000282987100006
dc.identifier.issn0036-5548
2011 Impact Factor: 1.722
2011 SCImago Journal Rankings: 0.145
dc.identifier.issue10
dc.identifier.pmid20524786
dc.identifier.scopuseid_2-s2.0-77956819449
dc.identifier.spage757
dc.identifier.urihttp://hdl.handle.net/10722/130631
dc.identifier.volume42
dc.languageeng
dc.publisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/00365548.asp
dc.publisher.placeUnited Kingdom
dc.relation.ispartofScandinavian Journal of Infectious Diseases
dc.relation.referencesReferences in Scopus
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAnti-Bacterial Agents - pharmacology
dc.subject.meshFemale
dc.subject.meshGram-Positive Bacterial Infections - epidemiology - microbiology - mortality - physiopathology
dc.subject.meshHong Kong - epidemiology
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMicrobial Sensitivity Tests
dc.subject.meshMiddle Aged
dc.subject.meshPrognosis
dc.subject.meshRetrospective Studies
dc.subject.meshRisk Factors
dc.subject.meshShewanella - classification - drug effects - isolation & purification - pathogenicity
dc.titleEpidemiology and clinical features of Shewanella infection over an eight-year period
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong
  2. Queen Mary Hospital Hong Kong